2SEVENTY BIO INC (TSVT) Stock Analyst Ratings
NASDAQ:TSVT - Nasdaq - US9013841070 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 77% to TSVT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.63. This target is 154.02% above the current price.
TSVT was analyzed by 12 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about TSVT.
In the previous month the buy percentage consensus was at a similar level.
TSVT was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-07-29 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-06-27 | Wedbush | Reiterate | Neutral -> Neutral |
| 2024-05-09 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-04-08 | Citigroup | Maintains | Buy -> Buy |
| 2024-03-18 | Wedbush | Reiterate | Neutral -> Neutral |
| 2024-01-31 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2024-01-31 | TD Cowen | Downgrade | Outperform -> Market Perform |
| 2023-11-20 | Wedbush | Downgrade | Outperform -> Neutral |
| 2023-10-30 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2023-10-12 | Citigroup | Initiate | Buy |
| 2023-09-13 | Guggenheim | Downgrade | Buy -> Neutral |
| 2023-09-13 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2023-09-12 | Guggenheim | Downgrade | Buy -> Neutral |
| 2023-08-15 | Guggenheim | Maintains | Buy -> Buy |
| 2023-08-15 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-07-28 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-07-28 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2023-07-20 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-05-18 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-05-15 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-03-17 | Wedbush | Maintains | Outperform |
| 2023-01-24 | Morgan Stanley | Maintains | Overweight |
| 2023-01-20 | Goldman Sachs | Maintains | Buy |
| 2023-01-10 | SVB Leerink | Maintains | Outperform |
| 2022-11-08 | SVB Leerink | Maintains | Outperform |
| 2022-11-08 | Morgan Stanley | Maintains | Overweight |
| 2022-10-31 | Guggenheim | Initiate | Buy |
| 2022-08-15 | Morgan Stanley | Maintains | Overweight |
| 2022-07-15 | Morgan Stanley | Maintains | Overweight |
| 2022-05-17 | Morgan Stanley | Maintains | Overweight |